Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q2
$22.6M Buy
125,470
+4,432
+4% +$809K 0.27% 55
2021
Q1
$23.3M Buy
121,038
+86,966
+255% +$16.7M 0.27% 52
2020
Q4
$6.88M Buy
34,072
+1,264
+4% +$262K 0.08% 174
2020
Q3
$6.9M Sell
32,808
-1,446
-4% -$322K 0.09% 164
2020
Q2
$7.51M Sell
34,254
-126,290
-79% -$25.2M 0.1% 160
2020
Q1
$27.8M Sell
160,544
-56
-0% -$9.25K 0.44% 31
2019
Q4
$24.5M Buy
160,600
+134,044
+505% +$20M 0.25% 57
2019
Q3
$4.03M Sell
26,556
-639
-2% -$101K 0.04% 334
2019
Q2
$4.16M Sell
27,195
-99,000
-78% -$15.1M 0.04% 327
2019
Q1
$20.3M Sell
126,195
-2,000
-2% -$310K 0.22% 56
2018
Q4
$19.8M Sell
128,195
-9,578
-7% -$1.49M 0.25% 50
2018
Q3
$20.7M Sell
137,773
-8,963
-6% -$1.27M 0.2% 64
2018
Q2
$19.8M Buy
146,736
+97,414
+198% +$12M 0.2% 63
2018
Q1
$6.57M Buy
49,322
+712
+1% +$95.6K 0.07% 187
2017
Q4
$7.23M Buy
48,610
+3,472
+8% +$472K 0.07% 192
2017
Q3
$5.95M Sell
45,138
-29,620
-40% -$3.98M 0.05% 251
2017
Q2
$9.96M Buy
74,758
+11,019
+17% +$1.49M 0.08% 143
2017
Q1
$8.59M Sell
63,739
-21,540
-25% -$2.79M 0.07% 166
2016
Q4
$10.2M Sell
85,279
-22,098
-21% -$2.61M 0.08% 178
2016
Q3
$13.4M Sell
107,377
-895
-0.8% -$117K 0.11% 156
2016
Q2
$15M Buy
108,272
+38,771
+56% +$5.03M 0.13% 144
2016
Q1
$8.76M Sell
69,501
-2,330
-3% -$296K 0.08% 231
2015
Q4
$9.11M Sell
71,831
-42,052
-37% -$5.22M 0.09% 202
2015
Q3
$13.2M Sell
113,883
-8,656
-7% -$972K 0.14% 139
2015
Q2
$12.7M Sell
122,539
-41,323
-25% -$4.46M 0.16% 145
2015
Q1
$18.1M Buy
163,862
+39,712
+32% +$4.31M 0.21% 107
2014
Q4
$12.9M Buy
124,150
+118,317
+2,028% +$11.8M 0.15% 163
2014
Q3
$560K Sell
5,833
-200
-3% -$18.1K 0.02% 432
2014
Q2
$551K Buy
6,033
+1,833
+44% +$164K 0.01% 460
2014
Q1
$370K Sell
4,200
-2,500
-37% -$219K 0.01% 494
2013
Q4
$622K Sell
6,700
-1,000
-13% -$90.1K 0.02% 395
2013
Q3
$628K Sell
7,700
-1,800
-19% -$152K 0.03% 397
2013
Q2
$800K Buy
+9,500
New +$817K 0.03% 434

Other funds holding CLX

QS Investors's CLX Position: Q2 2021 in Review

QS Investors increased its Clorox (CLX) stake by 3.7% in Q2 2021, buying an estimated $809K and bringing the position to 125,470 shares worth $22.6M. The position accounts for 0.27% of the portfolio, ranked #55.

QS Investors first reported a position in CLX in Q2 2013 and has held it in 33 quarters since. The position peaked at $27.8M in Q1 2020. 1,168 funds tracked by Wall St. Rank hold CLX as of Q2 2021.

  • QS Investors held 125,470 shares of Clorox worth $22.6M as of Q2 2021.
  • QS Investors bought 4,432 Clorox shares in Q2 2021, an estimated $809K.
  • Clorox made up 0.27% of QS Investors's portfolio in Q2 2021, its #55 holding.
  • QS Investors first reported a position in Clorox in Q2 2013 and has held it in 33 quarters since.
  • QS Investors's Clorox position peaked at $27.8M in Q1 2020.
  • 1,168 funds tracked by Wall St. Rank held Clorox as of Q2 2021.

Based on QS Investors's 13F filing for Q2 2021, filed 13 Aug 2021.